Research Policy Analysis and Coordination
Clinical trials
The University of California participates in sponsor-initiated clinical trials and also conducts investigator-initiated trials. UC policy and guidance aligns the University’s goals of promoting research, academic freedom, and the safety of human subjects with its obligations as a healthcare provider and participant of clinical trials.
Policies & Guidance
University Policy on Copyright Ownership PDF
Effective February 1, 2021Contract and Grant Manual Chapter 18 Link
Protection of Research Subjects
RAO Memo 95-05 Link
February 15, 1995Requirements for Administration of Agreements with Private Sponsors for Drug and Device Testing Using Human Subjects
OTT Memo 96-03 Link
January 31, 1996University Patent Policy Interim Guidelines for Agreements with Private Sponsors for Drug and Device Testing Using Human Subjects
UC Patent Acknowledgment Link
UC employees, persons not employed by the university but who use UC research facilities, and persons who receive gift, grant or contract funds through the university are all required to sign the University Patent Acknowledgment.
FDA Guidance: Clinical Trials of Medical Products During Disasters and Public Health Emergencies PDF
Considerations for the Conduct of Clinical Trials of Medical Products During Major Disruptions Due to Disasters and Public Health Emergencies